Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interleukin-6 (Homo sapiens (Human)) | BDBM331838![]() ((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331841![]() ((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331840![]() ((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331839![]() ((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331836![]() ((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331837![]() ((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331842![]() (7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 83 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331844![]() (8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 93 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Interleukin-6 (Homo sapiens (Human)) | BDBM331843![]() (8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 123 | n/a | n/a | n/a | n/a | n/a | n/a |
Santen Pharmaceutical Co., Ltd US Patent | Assay Description o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti... | US Patent US10189796 (2019) BindingDB Entry DOI: 10.7270/Q21G0PBH | |||||||||||
More data for this Ligand-Target Pair |